Lilly India launches Olumiant to treat rheumatoid arthritis
Olumiant will be available in India starting October 2018 in 4 mg and 2 mg dosage forms
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Aurobindo Pharma receives US FDA approval for Azithromycin oral suspension
The product will be launched in November 2018
Aurobindo Pharma has received final approval from the US Food & Drug…
Govt aims to raise API production to cut Chinese dependence
In 2017, India imported APIs worth $ 2.5 billion from the neighbouring country
The government is working on a road map to increase…
EMA Brexit preparedness business continuity plan enters third phase
The agency has now drawn up priority lists of those guidelines and working parties, which will exceptionally continue during BCP…
Lupin launches generic Clobetasol Propionate Ointment in the US
Lupin,Clobetasol Propionate Ointment,United States Food and Drug Administration,FDA,dermatoses
Antiepileptic drugs linked to higher risk of stroke in persons with Alzheimer’s disease
The risk did not differ between old and new antiepileptic drugs; the results were published in the Journal of the American Heart…
Boehringer Ingelheim India inaugurates facility for children with special needs
The facility will educate children on how to communicate effectively and cultivate behavioural change essential in their daily…
Affimed puts on hold cancer drug trial after patient death
The company's shares slumped 25 per cent to $3.82 in after-market trading
Bausch Health’s plaque psoriasis lotion gets tentative FDA approval
The company plans to launch the lotion in November after receiving final approval from the Food and Drug Administration, pending…
US FDA expands approval of Roche hemophilia drug
Roche is looking to capture a big share of a $ 10 billion-per-year hemophilia market from established rivals like Shire, Bayer AG…